Virtue Capital Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-439
Closed -$222K – 274
2024
Q3
$222K Buy
439
+13
+3% +$6.32K 0.04% 242
2024
Q2
$201K Sell
426
-199
-32% -$99.9K 0.03% 362
2024
Q1
$310K Buy
625
+92
+17% +$50.3K 0.06% 289
2023
Q4
$286K Sell
533
-125
-19% -$58.7K 0.06% 294
2023
Q3
$324K Hold
658
– – 0.06% 291
2023
Q2
$324K Sell
658
-194
-23% -$93K 0.06% 289
2023
Q1
$410K Hold
852
– – 0.07% 250
2022
Q4
$348K Buy
+852
New +$331K 0.05% 264
2022
Q2
– Sell
-3,579
Closed -$1.96M – 340
2022
Q1
$1.96M Sell
3,579
-442
-11% -$233K 0.31% 66
2021
Q4
$2.65M Buy
4,021
+503
+14% +$316K 0.39% 55
2021
Q3
$2.19M Sell
3,518
-121
-3% -$81.3K 0.39% 53
2021
Q2
$2.3M Buy
3,639
+167
+5% +$92.2K 0.46% 42
2021
Q1
$1.7M Buy
3,472
+127
+4% +$63.6K 0.4% 54
2020
Q4
$1.67M Sell
3,345
-294
-8% -$132K 0.41% 58
2020
Q3
$1.43M Sell
3,639
-152
-4% -$56.2K 0.35% 80
2020
Q2
$1.25M Buy
+3,791
New +$1.1M 0.29% 102
2020
Q1
– Sell
-2,156
Closed -$563K – 115
2019
Q4
$563K Buy
2,156
+571
+36% +$150K 0.16% 123
2019
Q3
$431K Buy
1,585
+567
+56% +$158K 0.14% 154
2019
Q2
$280K Buy
+1,018
New +$251K 0.1% 172

Other funds holding IDXX

Virtue Capital Management's IDXX Position: Q4 2024 in Review

Virtue Capital Management sold out of Idexx Laboratories (IDXX) in Q4 2024, closing a stake of 439 shares — an estimated $222K sold.

Virtue Capital Management first reported a position in IDXX in Q2 2019 and held it in 19 quarters. The position peaked at $2.65M in Q4 2021. 1,125 funds tracked by Wall St. Rank hold IDXX as of Q4 2024.

  • Virtue Capital Management reported no remaining Idexx Laboratories position as of Q4 2024 after selling out during the quarter.
  • Virtue Capital Management sold 439 Idexx Laboratories shares in Q4 2024, an estimated $222K.
  • Virtue Capital Management first reported a position in Idexx Laboratories in Q2 2019 and held it in 19 quarters.
  • Virtue Capital Management's Idexx Laboratories position peaked at $2.65M in Q4 2021.
  • 1,125 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2024.

Based on Virtue Capital Management's 13F filing for Q4 2024, filed 26 Feb 2025.